亚虹医药 (688176) 财务报表

截止日期2022-09-302022-06-302022-03-312021-12-312021-09-30
营业总收入(万元)1.690.910.910.46--
营业收入(万元)1.690.910.910.46--
营业总成本(万元)20988.2311850.405533.1625511.5018307.28
营业成本(万元)0.570.140.140.07--
净利润(万元)-16281.75-8960.67-4729.44-23494.93-17150.21
归属于母公司的净利润(万元)-16281.75-8960.67-4729.44-23494.93-17150.21
营业利润(万元)-16396.42-8977.23-4729.44-23835.39-17460.61
利润总额(万元)-16167.83-8827.23-4729.44-23475.43-17100.61
少数股东损益(万元)----------
基本每股收益(元)-0.29(元)-0.16(元)-0.08(元)-0.51(元)--
稀释每股收益(元)-0.29(元)-0.16(元)-0.08(元)-0.51(元)-0.37(元)
非经常性损益(万元)4623.973011.33793.69-3971.62-4908.10
扣除非经常性损益后净利润(万元)-20905.73-11972.00-5523.13-19523.31--
总资产(万元)295072.84301138.97303066.08309885.7275606.16
总负债(万元)9917.598811.466507.348597.536032.48
归属于母公司股东权益合计(万元)285155.25292327.52296558.74301288.1869573.68
股东权益合计(万元)285155.25292327.52296558.74301288.1869573.68
实收资本(股本)(万元)57000.0057000.0057000.0057000.0046000.00
资本公积(万元)284273.29284080.39284080.39284080.3957021.18
未分配利润(万元)-56073.97-48752.88-44521.66-39792.21-33447.50
经营活动产生的现金流量净额(万元)-16722.58-9554.94-6922.95-17151.59-11021.09
经营活动现金流入小计(万元)4012.882616.26725.041146.59886.42
经营活动现金流出小计(万元)20735.4612171.207647.9818298.1811907.51
投资活动产生的现金流量净额(万元)-171745.14-174871.16-195702.2512333.1211339.61
投资活动现金流入小计(万元)132440.9745910.7619637.0974970.4859635.74
投资活动现金流出小计(万元)304186.12220781.92215339.3462637.3648296.13
筹资活动产生的现金流量净额(万元)-2771.05-2453.82-1630.32238381.74-804.59
筹资活动现金流入小计(万元)------239636.00--
筹资活动现金流出小计(万元)2771.052453.821630.321254.26804.59
期末现金及现金等价物余额(万元)71065.8474954.5357072.09261318.7427375.12
最后修改日期2022-10-292022-08-242022-04-272022-04-142021-12-18